Back to News
Market Impact: 0.2
Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm Regarding a Securities Investigation
Source: newsfilecorp.com
Legal & Litigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities-law violations involving Cellebrite DI Ltd. (NASDAQ: CLBT). The announcement signals legal and reputational risk for Cellebrite, but provides no allegations, financial damages, or case-specific details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CLBT-0.80
More News
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Bloomberg News Now
- The Pentagon is investigating if rogue freezers are tied to cyberattacks in France. Another wave of hacks is hitting supermarkets across Europe
- Apple may try to increase revenue by doing…something with third-party AI apps
- Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future
- Snap settles social media addiction lawsuit to avoid trial